ReviewAJR. American journal of roentgenology2022
Imaging Surveillance Options for Individuals With a Personal History of Breast Cancer:
Review in AJR. American journal of roentgenology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 24 citations in OpenAlex.
- Patient- and Physician-Identified Considerations for Clinical Implementation of a New Risk-Based Prediction Tool to Guide Surveillance Mammography in Breast Cancer Survivors.JCO oncology practice · 2026Article
- Evaluating double-reading mammography for long-term surveillance in breast cancer survivors: a retrospective exploratory analysis from a single center.La Radiologia medica · 2026Article
- ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.European radiology · 2026Review
- Patient and Physician Perspectives on Using Risk Prediction to Support Breast Cancer Surveillance Decision Making.Medical decision making : an international journal of the Society for Medical Decision Making · 2026Article
- Clinicopathological features and diagnostic intervals of second primary breast cancer following a prior malignancy: a single-center retrospective study.Frontiers in oncology · 2026Article
- Intra- and peritumoral radiomics for predicting equivocal HER2 status of breast cancer on contrast-enhanced mammography.Frontiers in oncology · 2026Article
- Contrast-Enhanced Mammography in Breast Cancer Follow-Up: Diagnostic Value in Suspected Recurrence.Journal of imaging · 2025Article
- Prospective Multicenter Study Comparing Magnetic Resonance Imaging and Ultrasonography for Second Breast Cancer Surveillance in Women With Prior Breast Cancer and Dense Breasts: KBCSG-27 Trial.Journal of breast cancer · 2025Article
- Application of a Commercial Artificial Intelligence Software in Unilateral Mammography: Simulating Total Mastectomy Scenarios.Journal of imaging informatics in medicine · 2025Article
- Preoperative Predictors of Subsequent Breast Cancer Events Detected on Abbreviated MRI in Patients with Early-Stage Breast Cancer.Diagnostics (Basel, Switzerland) · 2025Article
- Integration of AI lesion classification, age, and BI-RADS assessment to reduce benign biopsies on breast ultrasound.European radiology · 2025Article
- Surveillance Outcomes by Imaging Methods in the First 5 Years After Breast Cancer Surgery.Korean journal of radiology · 2025Article
- Contrast-enhanced mammography for surveillance in women with a personal history of breast cancer.Breast cancer research and treatment · 2024Article
- MR-contrast enhanced mammography (CEM) for follow-up of breast cancer patients: a "pros and cons" debate.European radiology · 2024Article
- Predicting five-year interval second breast cancer risk in women with prior breast cancer.Journal of the National Cancer Institute · 2024Article
- Impact of Surveillance Mammography Intervals Less Than One Year on Performance Measures in Women With a Personal History of Breast Cancer.Korean journal of radiology · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
Abstract
Annual surveillance mammography is recommended for breast cancer survivors on the basis of observational studies and meta-analyses showing reduced breast cancer mortality and improved quality of life. However, breast cancer survivors are at higher risk of subsequent breast cancer and have a fourfold increased risk of interval breast cancers compared with individuals without a personal history of breast cancer. Supplemental surveillance modalities offer increased cancer detection compared with mammography alone, but utilization is variable, and benefits must be balanced with possible harms of false-positive findings. In this review, we describe the current state of mammographic surveillance, summarize evidence for supplemental surveillance in breast cancer survivors, and explore a risk-based approach to selecting surveillance imaging strategies. Further research identifying predictors associated with increased risk of interval second breast cancers and development of validated risk prediction tools may help physicians and patients weigh the benefits and harms of surveillance breast imaging and decide on a personalized approach to surveillance for improved breast cancer outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.